ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/26/2026
Back to search
Official data from USPTO
MEPERITAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
01/27/2026
Trademark type
Word
Nice classes
5
Filing date
12/06/1999
Registration date
10/30/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2021
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/30/2000
First use in commerce
11/30/2000
Drawing code
1
Owner type
99
Owner location
BALLSBRIDGE, DUBLIN 4, IE
Examiner
MOONEYHAM, JANICE
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
GENERICS BIDCO I, LLC
Qualitest Pharmaceuticals, Inc.
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparation for pain relief
Publications
History of USPTO decisions and trademark events.
45 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/28/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/22/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/02/2021
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/02/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/02/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/01/2021
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
01/29/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/26/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
11/03/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/25/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/25/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/26/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/12/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/10/2011
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/10/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/20/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/22/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/22/2011
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/29/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/29/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
11/24/2010
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/04/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/17/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/07/2007
PLGL
ASSIGNED TO PARALEGAL
03/02/2007
CFIT
CASE FILE IN TICRS
01/19/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
12/15/2006
PAPER RECEIVED
12/15/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/12/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/05/2001
IUAF
USE AMENDMENT FILED
04/30/2001
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/27/2001
PUBO
PUBLISHED FOR OPPOSITION
01/02/2001
NPUB
NOTICE OF PUBLICATION
12/01/2000
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2000
CNEA
EXAMINER'S AMENDMENT MAILED
07/14/2000
CNRT
NON-FINAL ACTION MAILED
06/20/2000
DOCK
ASSIGNED TO EXAMINER
06/17/2000
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/31/2000
Continuous trademark protection
Get notified about every new filing that threatens MEPERITAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.